Status:
RECRUITING
Effect of Nitrate Supplementation on Blood Pressure and Microvascular Function of Resistant Hypertensive Patients
Lead Sponsor:
National Institute of Cardiology, Laranjeiras, Brazil
Conditions:
Arterial Hypertension
Resistant Hypertension
Eligibility:
All Genders
18-75 years
Phase:
EARLY_PHASE1
Brief Summary
Arterial hypertension (AH) has been identified as an important public health problem and considered a new epidemic with high mortality and morbidity. High blood pressure (BP) levels increase the chanc...
Eligibility Criteria
Inclusion
- Resistant hypertension, with a diagnosis described in the medical record, without changing medications or increasing doses in the last 30 days.
Exclusion
- neoplasms
- heart failure
- use of medications with nitrate in their formula
- patients undergoing renal denervation
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06169241
Start Date
November 1 2023
End Date
December 1 2025
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Cardiology
Rio de Janeiro, Brazil, 21040-360